For more than 20 years, Dr. Christopher Wheeler has served as a professor and research scientist at Cedars-Sinai Medical Center in Los Angeles, California. One of the country’s top researchers and scientists in the area of brain tumor immunology, immunotherapy and neurological diseases, Dr. Wheeler was inspired by his mother’s early-onset AD to start a series of experiments that ultimately led to his technology that forms the basis for the science behind TNeuroPharma. Dr. Wheeler serves as the company’s Chief Scientific Officer, bringing his decades of scientific research in this complex area and his research into the role of T-cells in neurodegenerative diseases to TNeuroPharma.
Dr. Wheeler has published more than 30 peer-reviewed articles, including being featured on multiple journal covers throughout the years, and has received numerous honors for his scientific research and findings. He has received grants from Leukemia and Lymphoma Society and NIH, several private foundations and donors (Milken, Mashouf, Jos. Drown, Uncle Kory, Precision Medicine). He received his BA in Biological Science at the University of California, Santa Barbara, his PhD. in Immunology at the University of California, Berkeley and his postdoc in Immunology from Stanford University.